As of 2024-12-12, the Fair Value of Cara Therapeutics Inc (CARA) is -8.71 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 USD, the upside of Cara Therapeutics Inc is -3,360.77%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -106.40 | 8.40 | -88.40 | -85.50 | -118.51 | -78.08 |
| YoY growth | -43.78% | 107.89% | -1,152.38% | 3.28% | -38.61% | -224.72% |
| Market Cap (mil) | 14.65 |
| P/E | |
| Forward P/E |
| EPS | -1.74 |
| Avg earnings growth rate | -224.72% |
| TTM earnings | -95.53 |